Non-invasive vagus nerve stimulation for treatment of cluster headache: early UK clinical experience
Open Access
- 23 November 2018
- journal article
- research article
- Published by Springer Nature in The Journal of Headache and Pain
- Vol. 19 (1) , 1-6
Abstract
Evidence supports the use of non-invasive vagus nerve stimulation (nVNS; gammaCore®) as a promising therapeutic option for patients with cluster headache (CH). We conducted this audit of real-world data from patients with CH, the majority of whom were treatment refractory, to explore early UK clinical experience with nVNS used acutely, preventively, or both. We retrospectively analysed data from 30 patients with CH (29 chronic, 1 episodic) who submitted individual funding requests for nVNS to the National Health Service. All patients had responded to adjunctive nVNS therapy during an evaluation period (typical duration, 3–6 months). Data collected from patient interviews, treatment diaries, and physician notes were summarised with descriptive statistics. Paired t tests were used to examine statistical significance. The mean (SD) CH attack frequency decreased from 26.6 (17.1) attacks/wk. before initiation of nVNS therapy to 9.5 (11.0) attacks/wk. (P < 0.01) afterward. Mean (SD) attack duration decreased from 51.9 (36.7) minutes to 29.4 (28.5) minutes (P < 0.01), and mean (SD) attack severity (rated on a 10-point scale) decreased from 7.8 (2.3) to 6.0 (2.6) (P < 0.01). Use of abortive treatments also decreased. Favourable changes in the use of preventive medication were also observed. No serious device-related adverse events were reported. Significant decreases in attack frequency, severity, and duration were observed in these patients with CH who did not respond to or were intolerant of multiple preventive and/or acute treatments. These real-world findings complement evidence from clinical trials demonstrating the efficacy and safety of nVNS in CH.Keywords
Funding Information
- electroCore, Inc. (Not applicable)
This publication has 17 references indexed in Scilit:
- Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A randomized, double-blind, sham-controlled ACT2 studyCephalalgia, 2017
- Non-invasive vagus nerve stimulation for the management of refractory primary chronic headaches: A real-world experienceCephalalgia, 2017
- Abnormal tyrosine metabolism in chronic cluster headacheCephalalgia, 2016
- Non–Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double‐Blind, Sham‐Controlled ACT1 StudyHeadache: The Journal of Head and Face Pain, 2016
- Cluster headache attack remission with sphenopalatine ganglion stimulation: experiences in chronic cluster headache patients through 24 monthsThe Journal of Headache and Pain, 2016
- Non-invasive vagus nerve stimulation for PREVention and Acute treatment of chronic cluster headache (PREVA): A randomised controlled studyCephalalgia, 2015
- Cortical plasticity in episodic and chronic cluster headacheNeuroImage: Clinical, 2014
- The International Classification of Headache Disorders, 3rd edition (beta version)Cephalalgia, 2013
- Cluster Headache—Acute and Prophylactic TherapyHeadache: The Journal of Head and Face Pain, 2011
- Quality of life and disability in primary chronic daily headachesNeurological Sciences, 2003